In certain cancer patient populations, both KCa3.1 activity and calmodulin expression are reduced, with the downregulation of membrane-proximal calmodulin being responsible for the suppression of KCa3.1 activity and consequently limiting the ability of these T cells to infiltrate the adenosine-rich tumor microenvironment. The gene discussed is KCNN4; the disease is neoplasm.